Navigation Links
PrimeraDx Names Fayyaz Memon Vice President of Regulatory Affairs and Quality Assurance

MANSFIELD, Mass., Aug. 2, 2011 /PRNewswire/ -- PrimeraDx today announced that Fayyaz Memon has been appointed to the position of Vice President of Regulatory Affairs and Quality Assurance.  

"We are very pleased to have Fayyaz join our team during such an exciting period for the Company," stated President and CEO Matthew McManus.   "Fayyaz comes at a key time, as we've recently launched our first product based on our unique technology for multiplex quantitative PCR, and we will be going to the FDA for clearance later this year.  Fayyaz will bring much needed expertise to take our Quality Systems to the next level and manage our regulatory submissions."

Mr. Memon joins PrimeraDx with over 20 years of experience as an executive in the life sciences and chemical industries.  He has held management positions with Thermo Fisher Scientific, Digene, Johnson&Johnson and SmithKline Beecham and has helped numerous companies to obtain FDA clearances and approvals and to establish quality systems.  He has a unique background covering quality systems, regulatory affairs, FDA remedial actions, software and process validation, manufacturing, and clinical trial services.  Mr. Memon earned his MBA in Operation and Quality Management and MS in Mechanical Engineering from Drexel University.  

"It is a very exciting time to join PrimeraDx!  Not only has the company recently begun commercialization of its core technology, but we are also poised to be a leader in the field of personalized medicine," commented Mr. Memon.  "I believe the product pipeline at PrimeraDx will have a significant impact on patient management, and will help realize the value of genomic medicine."

About PrimeraDx

PrimeraDx is dedicated to the high growth field of molecular diagnostics.  The Company has developed a unique platform for high-multiplex, quantitative, real-time PCR based on its proprietary STAR technology, implemented on the walk-away ICEPlex® instrument system.  PrimeraDx is developing a broad range of applications in oncology, infectious disease, companion diagnostics and multiple non-clinical molecular markets, both through its own efforts and in collaboration with partners.  The Company is backed by a strong group of experienced venture-capital investors, including Abingworth, InterWest Partners, CHL Medical Partners, and Malaysia Technology Development Corporation.  The Company's website is: or

CONTACT: Andrew Bond, 508-618-2300,

SOURCE PrimeraDx
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US
2. Axial Biotech Names New VP of Reimbursement and Regulatory Affairs
3. Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications
4. Genstruct Names Louis Latino VP of Sales
5. Codexis Names Vice President, Intellectual Property
6. New England Peptide Names Director of Chemical Development
7. Horizon Therapeutics Names Robert J. De Vaere Executive Vice President and Chief Financial Officer
8. Board of Directors of Milestone Scientific Names Joseph DAgostino Chief Financial Officer
9. PercSys Names David Auth and Howard Palefsky to Its Board of Directors
10. Sustainable Oils Names Scott Johnson as General Manager, Expands Management Team for Camelina Research and Production
11. BioAuthorize Holdings, Inc. Names New Directors and Executive and Unveils Modification to Its Voice Biometric Authentication Service
Post Your Comments:
(Date:10/13/2015)... , October 13, 2015 the United ... Europe .  PRCC represents about 14% of all new cases ... , Canada and Europe ... kidney cancer.   --> Hutchison China MediTech Limited ("Chi-Med") ... R&D subsidiary, and AstraZeneca AB (publ) ("AstraZeneca") have completed enrolment in ...
(Date:10/12/2015)... , Oct. 12, 2015  Rebiotix Inc. ... (FDA) has designated its lead Microbiota Restoration Therapy ... treatment of recurrent Clostridium difficile (C ... infection that causes 29,000 deaths in the U.S. ... biotechnology company that was founded to revolutionize the ...
(Date:10/12/2015)... , October 12, 2015 ... Dario™ Diabetes Management Solution, today announced its Medical Director, ... case study at MobiHealth,s 5th EAI International Conference ... "Transforming healthcare through innovations in mobile and wireless technologies," ... England from October 14 - 16, 2015. ...
(Date:10/12/2015)... CA (PRWEB) , ... October 12, 2015 , ... ... announced the launch of LifeTrak Zoom, the world’s first amphibious fitness tracker that seeks ... that offers flexwear technology and accurate heart rate monitoring both in water ...
Breaking Biology Technology:
(Date:9/30/2015)... -- The global glucose monitoring device and diabetes management market is ... report on the industry from Kalorama Information. Sales in the traditional ... by continuous glucose monitoring and sensor segment, according to the ... products in its latest report, The Global Glucose Monitoring ... , ...
(Date:9/28/2015)... -- The global image sensors market ... by 2020, growing at a CAGR of 4.6% from ... (BSI) technique to improve picture quality are expected to ...      (Logo: , The light falls ... and, thus, reduce the noise interference and increase picture ...
(Date:9/24/2015)... LONDON , September 24, 2015 /PRNewswire/ ... 00.01 25 september 2015 Kerv ... inom digitala finanstjänster, lanserar idag världens första ... att samla in 77 000 GBP för ... ) , ...
Breaking Biology News(10 mins):